![How 6 Leading Brands Use Content To Win Audiences [E-Book]](https://contentmarketinginstitute.com/wp-content/uploads/2025/03/content-marketing-examples-600x330.png?#)
![Building A Digital PR Strategy: 10 Essential Steps for Beginners [With Examples]](https://buzzsumo.com/wp-content/uploads/2023/09/Building-A-Digital-PR-Strategy-10-Essential-Steps-for-Beginners-With-Examples-bblog-masthead.jpg)
![How Human Behavior Impacts Your Marketing Strategy [Video]](https://contentmarketinginstitute.com/wp-content/uploads/2025/03/human-behavior-impacts-marketing-strategy-cover-600x330.png?#)
![How to Use GA4 to Track Social Media Traffic: 6 Questions, Answers and Insights [VIDEO]](https://www.orbitmedia.com/wp-content/uploads/2023/06/ab-testing.png)
Biostatistician - New York
A company is looking for a Biostatistician - Late Phase Oncology. Key Responsibilities Support late-phase oncology trials, focusing on SAS, CDISC, and ADaM Develop and review protocols, statistical analysis plans, and clinical trial documents Collaborate with the statistical programming team to guide statistical analyses and reporting Required Qualifications PhD degree in Statistics or Biostatistics 3+ years of experience in analyzing clinical trial data and managing SAS programming Expertise in CDISC and ADaM standards within the pharmaceutical and biotechnology industry Experience in Phase II/III Oncology trials Knowledge of clinical trial design, analysis, and interpretation
A company is looking for a Biostatistician - Late Phase Oncology.
Key Responsibilities
Support late-phase oncology trials, focusing on SAS, CDISC, and ADaM
Develop and review protocols, statistical analysis plans, and clinical trial documents
Collaborate with the statistical programming team to guide statistical analyses and reporting
Required Qualifications
PhD degree in Statistics or Biostatistics
3+ years of experience in analyzing clinical trial data and managing SAS programming
Expertise in CDISC and ADaM standards within the pharmaceutical and biotechnology industry
Experience in Phase II/III Oncology trials
Knowledge of clinical trial design, analysis, and interpretation